From Pipeline Progress to Precision Care: Five Takeaways from Two Leading MASH Conferences

With the first MASH therapies approved, the field has moved on. At the Paris MASH Meeting and the MASH Drug Development Summit in Boston, the talk was of combinations, patient finding, life beyond biopsy and real-world evidence. Here are five takeaways for your next study.